We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+11.73%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$194M
AUM Growth
-$78M
Cap. Flow
-$87.1M
Cap. Flow %
-44.94%
Top 10 Hldgs %
40.18%
Holding
105
New
33
Increased
15
Reduced
10
Closed
42

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$10.1M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$4.72M
3
CNMD icon
CONMED
CNMD
+$4.58M
4
PODD icon
Insulet
PODD
+$4.57M
5
CI icon
Cigna
CI
+$4.53M

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$9.42M
2
RMD icon
ResMed
RMD
+$8.01M
3
EW icon
Edwards Lifesciences
EW
+$4.71M
4
AGN
Allergan Inc
AGN
+$4.52M
5
EXAS
Exact Sciences
EXAS
+$4.41M

Sector Composition

Rank Sector Weight
1 Healthcare 54.96%
2 Financials 0%
3 Utilities 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRC
26
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$2.94M 1.52%
60,000
+10,000
+20% +$476K
COO icon
27
Cooper Companies
COO
$15B
$2.81M 1.45%
+60,000
New +$2.53M
AKRX
28
DELISTED
Akorn Inc
AKRX
$2.8M 1.45%
+59,000
New +$2.68M
NVCN
29
DELISTED
Neovasc Inc.
NVCN
$2.79M 1.44%
12
-1
-8% -$219K
CI icon
30
CALL
Cigna
CI
$72.2B
$2.59M 1.34%
+20,000
New +$2.32M
A icon
31
CALL
Agilent Technologies
A
$42.1B
$2.49M 1.29%
+60,000
New +$2.43M
TRNX
32
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$2.4M 1.24%
91,600
-7,400
-7% -$187K
TNDM icon
33
Tandem Diabetes Care
TNDM
$1.62B
$2.37M 1.22%
+18,774
New +$2.44M
ANGO icon
34
AngioDynamics
ANGO
$663M
$2.22M 1.15%
+125,000
New +$2.32M
DHR icon
35
CALL
Danaher
DHR
$145B
$2.12M 1.1%
+37,196
New +$2.13M
TEVA icon
36
Teva Pharmaceuticals
TEVA
$42.5B
$2.1M 1.08%
33,650
+2,150
+7% +$125K
CYBX
37
DELISTED
CYBERONICS INC
CYBX
$1.95M 1.01%
30,000
-66,200
-69% -$4.03M
ESPR
38
DELISTED
Esperion Therapeutics
ESPR
$1.85M 0.96%
20,000
+12,240
+158% +$790K
NXTM
39
DELISTED
NxStage Medical Inc.
NXTM
$1.8M 0.93%
104,116
-15,884
-13% -$281K
ALXN
40
DELISTED
Alexion Pharmaceuticals
ALXN
$1.73M 0.89%
10,000
+5,125
+105% +$928K
AFFX
41
DELISTED
Affymetrix Inc
AFFX
$1.63M 0.84%
+130,117
New +$1.51M
KITE
42
DELISTED
Kite Pharma, Inc.
KITE
$1.59M 0.82%
27,650
-16,600
-38% -$1.11M
CPRX
43
DELISTED
Catalyst Pharmaceutical
CPRX
$1.58M 0.82%
365,000
+50,000
+16% +$180K
SGYP
44
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$1.5M 0.77%
324,700
+74,700
+30% +$243K
ADYX
45
DELISTED
Adynxx Inc
ADYX
$1.27M 0.66%
+4,083
New +$1.33M
PTCT icon
46
CALL
PTC Therapeutics
PTCT
$6.15B
$913K 0.47%
+15,000
New +$915K
THOR
47
DELISTED
THORATEC CORPORATION
THOR
$838K 0.43%
+20,000
New +$763K
BDSI
48
PUT
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$814K 0.42%
+77,500
New +$1.06M
ASXC
49
DELISTED
Asensus Surgical, Inc.
ASXC
$768K 0.4%
+20,154
New +$760K
VNDA icon
50
Vanda Pharmaceuticals
VNDA
$299M
$748K 0.39%
80,383
+30,383
+61% +$343K
1
2
3 4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2015 Portfolio in Review

As of Q1 2015, Pura Vida Investments held 105 positions worth $194M, down 29% from $272M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Pura Vida Investments withdrew a net $87.1M in Q1 2015, closing 42 positions and reducing 10 holdings. Its most notable exit was Intuitive Surgical, an estimated $9.42M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 33% a quarter earlier, followed by Financials and Utilities.

Against the trend, Pura Vida Investments opened a new position in Baxter International worth $9.93M.

  • Pura Vida Investments's largest Q1 2015 buy was Baxter International: 266,945 shares worth $9.93M.
  • Pura Vida Investments added most to Jazz Pharmaceuticals in Q1 2015, an estimated $4.72M increase.
  • Pura Vida Investments's biggest Q1 2015 reduction was Edwards Lifesciences, cutting an estimated $4.71M.
  • Pura Vida Investments fully exited Intuitive Surgical in Q1 2015, selling an estimated $9.42M.
  • Pura Vida Investments's ten largest holdings make up 40% of its $194M portfolio in Q1 2015.
  • Pura Vida Investments opened 33 new positions and closed 42 in Q1 2015.
  • Pura Vida Investments's portfolio value fell 29% quarter-over-quarter to $194M.

Based on Pura Vida Investments's 13F filing for Q1 2015, filed 14 May 2015.